19-19266513-C-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001001524.3(TM6SF2):​c.901G>T​(p.Val301Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000576 in 1,614,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00027 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000036 ( 0 hom. )

Consequence

TM6SF2
NM_001001524.3 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.960
Variant links:
Genes affected
TM6SF2 (HGNC:11861): (transmembrane 6 superfamily member 2) Enables identical protein binding activity. Involved in regulation of lipid metabolic process. Located in endoplasmic reticulum membrane and endoplasmic reticulum-Golgi intermediate compartment membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.03648871).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TM6SF2NM_001001524.3 linkuse as main transcriptc.901G>T p.Val301Leu missense_variant 9/10 ENST00000389363.5 NP_001001524.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TM6SF2ENST00000389363.5 linkuse as main transcriptc.901G>T p.Val301Leu missense_variant 9/101 NM_001001524.3 ENSP00000374014 P1Q9BZW4-1
TM6SF2ENST00000431465.2 linkuse as main transcriptn.1297G>T non_coding_transcript_exon_variant 6/72
TM6SF2ENST00000590431.6 linkuse as main transcriptn.204G>T non_coding_transcript_exon_variant 1/23
TM6SF2ENST00000591001.5 linkuse as main transcriptn.1235G>T non_coding_transcript_exon_variant 6/72

Frequencies

GnomAD3 genomes
AF:
0.000269
AC:
41
AN:
152204
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000893
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.0000601
AC:
15
AN:
249436
Hom.:
0
AF XY:
0.0000370
AC XY:
5
AN XY:
135308
show subpopulations
Gnomad AFR exome
AF:
0.000452
Gnomad AMR exome
AF:
0.000174
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.0000356
AC:
52
AN:
1461756
Hom.:
0
Cov.:
31
AF XY:
0.0000330
AC XY:
24
AN XY:
727174
show subpopulations
Gnomad4 AFR exome
AF:
0.00102
Gnomad4 AMR exome
AF:
0.000112
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.000132
GnomAD4 genome
AF:
0.000269
AC:
41
AN:
152322
Hom.:
0
Cov.:
31
AF XY:
0.000322
AC XY:
24
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.000890
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.0000866
Hom.:
0
Bravo
AF:
0.000310
ESP6500AA
AF:
0.000935
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000908
AC:
11
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 06, 2021The c.901G>T (p.V301L) alteration is located in exon 9 (coding exon 9) of the TM6SF2 gene. This alteration results from a G to T substitution at nucleotide position 901, causing the valine (V) at amino acid position 301 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0048
T
Eigen
Benign
-0.21
Eigen_PC
Benign
-0.071
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.81
T
M_CAP
Benign
0.0087
T
MetaRNN
Benign
0.036
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
L
MutationTaster
Benign
0.59
N
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-0.76
N
REVEL
Benign
0.033
Sift
Benign
0.18
T
Sift4G
Benign
0.31
T
Polyphen
0.0030
B
Vest4
0.34
MutPred
0.26
Loss of catalytic residue at V301 (P = 0.1708);
MVP
0.20
MPC
0.28
ClinPred
0.021
T
GERP RS
4.3
Varity_R
0.068
gMVP
0.63

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201595252; hg19: chr19-19377322; API